BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4281938)

  • 21. [Blood coagulation studies in patients with acute leukemia before and after cytostatic chemotherapy].
    Bhaduri S; Rasche H; Köhle W; Dietrich M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1142-4. PubMed ID: 611807
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathohysiological and biochemical aspects of the diagnosis of thrombosis].
    Markwárdt F; Eimleitung I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):109-14. PubMed ID: 50974
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution.
    Caprini JA; Kwaan HC; Zuckerman L; Verduin R
    Thromb Res; 1974 Feb; 4(2):199-217. PubMed ID: 4275415
    [No Abstract]   [Full Text] [Related]  

  • 24. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 25. The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally.
    Fletcher AP; Alkjaersig N; Fisher S; Sherry S
    J Lab Clin Med; 1966 Nov; 68(5):780-802. PubMed ID: 4224270
    [No Abstract]   [Full Text] [Related]  

  • 26. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of fibrinolysis on factor XIII assay].
    Suzuki H; Mikami K; Fujimaki M
    Rinsho Byori; 1970 Aug; 18(8):540-4. PubMed ID: 4248204
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombin generation in prothrombin-complex-preparations; its effect on a chromogenic substrate, fibrinogen and platelets.
    Kirchhof B; Söntgerath D; Kirchhof U; Etscheid G
    Thromb Res; 1990 Aug; 59(3):541-51. PubMed ID: 2237826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficiency and limits of immunologic methods in the diagnosis of blood coagulation].
    Schwick HG; Trobisch H; Heimburger N
    Internist (Berl); 1973 Apr; 14(4):160-9. PubMed ID: 4197663
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of leukocytes, plasmin and thrombin on clotting factors. A comparative in vitro study.
    Henriksson P; Nilsson IM
    Thromb Res; 1979; 16(3-4):301-12. PubMed ID: 160093
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
    Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
    Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modern data on the chemistry and physiology of fibrinogen].
    Andreenko GV
    Usp Sovrem Biol; 1974; 77(1):51-69. PubMed ID: 4282801
    [No Abstract]   [Full Text] [Related]  

  • 34. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of Echis carinata venom on hemostasis].
    Zimmermann H; Habermann E; Lasch HG
    Thromb Diath Haemorrh; 1971 Jun; 25(3):425-37. PubMed ID: 5561955
    [No Abstract]   [Full Text] [Related]  

  • 36. Activation of coagulation factors on the surface of platelets.
    Walsh PN
    Haematologia (Budap); 1984; 17(1):57-66. PubMed ID: 6427070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP
    Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological properties of dialysable peptides derived from plasmin digestion of bovine fibrinogen preparations.
    Buczko W; de Gaetano G; Franco R; Donati MB
    Thromb Haemost; 1976 Jun; 35(3):651-7. PubMed ID: 136056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of aminazine on blood coagulation].
    Novak EN
    Farmakol Toksikol; 1972; 35(6):717-20. PubMed ID: 4651808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.